By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Hoffmann-La Roche AG 

Emil-Barell-Stra├če 1

Grenzach-Wyhlen    D - 79639  Germany
Phone: 49-0-7624-142701 Fax: 49-0-7624-142640



Company News
Hoffmann-La Roche AG Release: Health Canada Approves TECENTRIQ (Atezolizumab) For Patients With Locally Advanced And Metastatic Bladder Cancer 4/18/2017 6:17:39 AM
ZIOPHARM, Inc. Elects George B. Abercrombie, former CEO of Hoffmann-La Roche AG, to Board of Directors 4/6/2010 10:23:54 AM
AstraZeneca AB, Merck & Co., Inc. (MRK), Novartis AG, H. Lundbeck A/S, Hoffmann-La Roche AG, And GlaxoSmithKline (GSK) Explore Advances in Solubility, Amorphous Forms and Lipid-Based Formulation of Drugs 2/4/2010 12:52:53 PM
Hoffmann-La Roche AG (JOBS) Says New Data Confirm Mabthera, Actemra Work 10/27/2008 6:54:39 AM
Hoffmann-La Roche AG's PEGASYS(R) Study Authors Conclude that Patients Successfully Treated for Hepatitis C Can be Considered "Cured" 5/22/2007 2:10:14 AM
Roche and Synosis Therapeutics Announce Partnership To Explore Potential Of Five Compounds Targeting The Central Nervous System 1/4/2007 11:42:40 AM
Hoffmann-La Roche AG Release: Xeloda(R) Plus Avastin(R) Combination May Produce Clinical Benefit In Patients With Advanced Breast Cancer 12/15/2006 11:02:50 AM
ArQule, Inc. (ARQL) Initiates Phase 1 Trial With ARQ 171, Provides Enrollment Update On ARQ 501 And ARQ 197 12/6/2006 11:30:21 AM
Roche (RHHBY) And InterMune, Inc. (ITMN) Sign $530M Agreement To Collaborate On The Research, Development And Commercialization Of Hepatitis C Protease Inhibitors 10/16/2006 5:07:09 PM
Herceptin "Linked To Heart Risk" 8/15/2006 9:48:29 AM